References
- Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG; RARECARE Working Group. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013 Feb;49(3):684–95. doi: 10.1016/j.ejca.2012.09.011. Epub 2012 Oct 15. PMID: 23079473.
- Lin, Yu-Hsuan et al. “Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.” Trends in molecular medicine vol. 23,8 (2017): 737–755. doi:10.1016/j.molmed.2017.06.004
- Nie, Zhigang, and Hao Peng. “Osteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes.” Oncology letters vol. 16,5 (2018): 6502–6514. doi:10.3892/ol.2018.9453
- Lamplot, Joseph D et al. “The Current and Future Therapies for Human Osteosarcoma.” Current cancer therapy reviews vol. 9,1 (2013): 55–77. doi:10.2174/1573394711309010006
- Ottaviani, Giulia, and Norman Jaffe. “The epidemiology of osteosarcoma.” Cancer treatment and research vol. 152 (2009): 3–13. doi:10.1007/978-1-4419-0284-9_1
- Sheng, Gaohong et al. “Osteosarcoma and Metastasis.” Frontiers in oncology vol. 11 780264. 10 Dec. 2021, doi:10.3389/fonc.2021.780264
- Tsukamoto, Shinji et al. “Current Treatment Considerations for Osteosarcoma Metastatic at Presentation.” Orthopedics vol. 43,5 (2020): e345–e358. doi:10.3928/01477447-20200721-05
- https://oncologypro.esmo.org/education-library/essentials-for- clinicians/sarcoma-gist-plus-cup/who-classification-of-bone-sar- comas-1. Accessed at dec. 2022.
- Strauss, S J et al. “Bone sarcomas: ESMO-EURACAN-GEN- TURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.” Annals of oncology: official journal of the European Society for Medical Oncology vol. 32,12 (2021): 1520–1536. doi:10.1016/j.annonc.2021.08.1995
- Kundu, Zile Singh. “Classification, imaging, biopsy and staging of osteosarcoma.” Indian journal of orthopaedics vol. 48,3 (2014): 238–46. doi:10.4103/0019-5413.132491
- Digesu, Christopher S et al. “Management of Sarcoma Metastases to the Lung.” Surgical oncology clinics of North America vol. 25,4 (2016): 721–33. doi:10.1016/j.soc.2016.05.005
- Marulli, Giuseppe et al. “Survival and prognostic factors following pulmonary metastasectomy for sarcoma.” Journal of thoracic disease vol. 9,Suppl 12 (2017): S1305–S1315. doi:10.21037/jtd.2017.03.177
- Lee, Rachel M., et al. ‘A Novel Preoperative Risk Score to Guide Patient Selection for Resection of Soft Tissue Sarcoma Lung Metastases: An Analysis from the United States Sarcoma Collaborative’. Journal of Surgical Oncology, vol. 124, no. 8, Wiley, Dec. 2021, pp. 1477–1484, https://doi.org10.1002/jso.26635.
- Lin, Anthony Y et al. “Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas.” The Journal of thoracic and cardiovascular surgery vol. 149,1 (2015): 85–92. doi:10.1016/j.jtcvs.2014.09.039
- Xie K, Zhang X, Tao Y. Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis. Signal Transduct Target Ther. 2020 Aug 24;5(1):161. doi: 10.1038/s41392-020- 00273-w. PMID: 32839478; PMCID: PMC7445174.
- Chang J, Zhao F, Sun X, Ma X, Zhi W, Yang Y. Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models. J Vis Exp. 2021 Oct 28;(176). doi: 10.3791/63072. PMID: 34779435.
- Wang S, Zhong L, Li Y, Xiao D, Zhang R, Liao D, Lv D, Wang X, Wang J, Xie X, Chen J, Wu Y, Kang T. Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma. Theranostics. 2019 Jun 9;9(15):4342–4353. doi: 10.7150/thno.34090. PMID: 31285765; PMCID: PMC6599655.
- Cristina Meazza & Paolo Scanagatta (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment, Expert Review of Anticancer Therapy, 16:5, 543–556, DOI: 10.1586/14737140.2016.1168697